Jazz Pharmaceuticals
JAZZ
JAZZ
388 hedge funds and large institutions have $7.72B invested in Jazz Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 118 increasing their positions, 155 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
388
Holders Change
+6
Holders Change %
+1.57%
% of All Funds
7.85%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.12%
New
65
Increased
118
Reduced
155
Closed
56
Calls
$112M
Puts
$99.9M
Net Calls
+$12.5M
Net Calls Change
+$37.9M
Top Buyers
| 1 |
BlackRock
New York
|
$869M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
$397M |
| 3 |
State Street
Boston,
Massachusetts
|
$308M |
| 4 |
DKCM
Davidson Kempner Capital Management
New York
|
$130M |
| 5 |
Holocene Advisors
New York
|
$117M |
Top Sellers
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
$184M |
| 2 |
Citadel Advisors
Miami,
Florida
|
$122M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
$39.2M |
| 4 |
Two Sigma Investments
New York
|
$947K |
| 5 |
Goldman Sachs
New York
|
$49M |
